Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 11.9227.2537.67-7.1420.14

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is 11.92 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202611.92
Mar202527.25
Mar202437.67
Mar2023-7.14
Mar202220.14

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 11.92
-56.26
Mar2025 27.25
-27.66
Mar2024 37.67
Positive
Mar2023 -7.14
Negative
Mar2022 20.14 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,421.9 Cr 1.7% 4.2% 1.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.7%

4.2%

1.8%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses